Tyrosine protein kinases and their substrates in human leukemia cells

• Published in: Leukemia research Vol. 9; no. 12; pp. 1443 - 1450
• Main Authors: Wickremasinghe, R.Gitendra, Piga, Andrea, Mire, Anthony R., Taheri, M.Reza, Yaxley, John C., Hoffbrand, A.Victor
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Ltd 1985; Elsevier Science
• Subjects: Biological and medical sciences; bone marrow; Bone Marrow - enzymology; Cell Division; Cytosol - enzymology; Hematologic and hematopoietic diseases; Humans; leukemia; Leukemia - enzymology; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; lymphocyte; Lymphocytes - enzymology; Medical sciences; Phosphorylation; Protein-Tyrosine Kinases - analysis; regulation of proliferation; Tyrosine protein kinase; AML; leukemia; ALL; CLL; regulation of proliferation; Tyrosine protein kinase; CGL; kD; bone marrow; TPK; lymphocyte; Human; Substrate; Enzymatic activity; Protein kinase; Leukemia; Hemopathy; Cytosol; Tumor cell
• ISSN: 0145-2126; 1873-5835
• DOI: 10.1016/0145-2126(85)90034-7

We have quantitated tyrosine protein kinase (TPK) activity in particulate and cytosolic fractions from human leukemia cells. Slowly proliferating cells from patients with chronic lymphocytic leukemia (CLL) had levels of TPK similar to those of quiescent normal lymphocytes. Cells from patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) and chronic granulocytic leukemia (CGL) contained markedly lower levels of TPK activity, similar to the levels in phytohaemagglutinin-stimulated (proliferating) normal lymphocytes and in bone marrow cells. This suggested that TPK is part of a mechanism for transducing growth signals and is down-regulated following signal transmission. We also identified endogenous substrates for TPK in leukemic cells. Particulate fractions from ALL, CLL and AML cells contained substrates identical to those previously detected in normal lymphocytes. In particular, a 38kD substrate thought to be involved in early stages of growth signal transduction in normal lymphocytes was found in all samples of these groups examined. Cytosolic fractions from these groups of leukemia cells contained higher molecular weight substrates not found in resting or proliferating normal lymphocytes or bone marrow cells. In contrast, TPK substrates in both particulate and cytosolic fractions from CGL cells resembled those of normal bone marrow cells in that only proteins with molecular weight below 40kD were labelled on tyrosine. We conclude that leukemic cells do not contain higher levels of TPK than do normal hemopoietic cells. Qualitative differences in TPK species or in their substrates may result in aberrant regulation of proliferation in leukemic cells. However, we cannot exclude the possibility that additional TPK substrates detected in leukemic cells were a feature of the normal equivalent hematopoietic cells from which the leukemia cells were derived.